NIPPON SANSO Corporation

About NIPPON SANSO Corporation

NIPPON SANSO Corporation is a Other / Uncategorized company; the kind of vendor BD teams should have a 15-minute conversation with at SNMMI.

Longer summary placeholder. Replace once Bracken finalizes the exhibitor profile copy.

What we're seeing

• STAT News · 2026-04-25
  Nippon Sanso Corporation partners with academic center on Actinium-225 program
  The work builds on more than a decade of radiochemistry collaboration.
• Imaging Wire · 2026-03-02
  Nippon Sanso Corporation files IND for next-generation PSMA-targeted agent
  The announcement comes amid tightening Mo-99 and Lu-177 supply.
• PR Newswire · 2026-10-11
  Nippon Sanso Corporation publishes dosimetry data at SNMMI 2026
  Details remain limited but analysts read the move as a positioning play ahead of pivotal data.
• Nuclear Medicine Today · 2026-05-28
  Nippon Sanso Corporation closes Series C round to scale radiopharma manufacturing
  Coverage notes the company's growing footprint in the radioligand therapy space.
• Endpoints News · 2026-12-09
  Nippon Sanso Corporation signs supply agreement to support late-stage trials
  The work builds on more than a decade of radiochemistry collaboration.

Mocked while we wire the Exa integration. Headlines are illustrative.

What we expect to see at the booth

Booth talking points, demos, and announcements to watch for. Bracken analyst note coming.